There’s a slight variation on an oft-quoted saying, “When the going gets tough, the tough get creative.” When times get especially challenging, those that make it through the rough patches successfully are those unafraid to try new, innovative things.
There’s no arena where that phrase is more true than the field of drug development. Pharmaceutical professionals and their research partners, already under ever-increasing pressure to get new treatments to market more rapidly, are finding themselves even more challenged in the face of the COVID-19 pandemic and all the new wrinkles the virus has added to clinical research—and what’s getting them through is innovation.
During our upcoming Outsourcing-Pharma editorial webinar, Clinical Development Innovations, we’ll be sharing presentations from some of the brightest minds and organizations in the field who are showing impressive levels of ingenuity, despite the incredible challenges the industry is facing right now. On April 6, 10 am CST (5 pm CET), join us to hear how next-level technologies like artificial intelligence, machine learning, remote monitoring solutions and other advanced tools are transforming the industry.
Speakers scheduled to lead the dynamic discussion include:
- Jean-Enno Charton, director of bioethics and digital ethics, Merck
- Ignacio Fuentes, managing director, MIT Jameel Clinic
- Nikhil Joshi, CEO, Clinical Trial Hero
I will be moderating the presentations, then leading a lively Q&A session at the last portion of the hour. As always, there is no cost to register and attend the 60-minute presentation, thanks to the generous contribution to our event sponsors:
- AIC, an LBB Specialties Company
- Florence
- PerkinElmer Inc.
I am very excited about the event, and I encourage you to sign up today. Please feel free to share the registration page link with your industry colleagues and friends—we are looking forward to the webinar, and we know you will find a great deal of value in what our experts have to share.
Hope to see you there!
